Dyslipidemias in the patients with end-stage renal disease on conventional hemodialysis in three months follow-up
Author(s) : Nighat Fatima, Saifullah Goraya & Sheraz Saleem
The objective of study was to determine the pattern of dyslipidemias in patients with end-stage renal disease on conventional hemodialysis in three months duration.
Material and Methods:
This study was conducted in the Department of Medicine and Dialysis Unit, Sargodha Medical College, District Headquarter Teaching Hospital, Sargodha. We conducted conventional hemodialysis (2cycles/week) for at least three hours and measured fasting lipid profile of 115 subjects with end-stage renal disease.
Our study included 115 subjects with end-stage renal disease. The mean age was 51.03 ±10.73 years. Out of 115 subjects, 69 (60%) were male and 46 (40%) were female. From study population, 39 (33.9%) patients were smokers and 76 (66.1%) patients were non-smokers. The mean baseline HDL cholesterol was 45.19±4.9 mg/dl, which after the end of study period was 41.07±8.57mg/dl. The difference was statistically significant as indicated by the p-value <0.001. The mean baseline triglyceride was significantly increased before and after the study. Almost all of our sample population exhibited elevated serum triglycerides and decreased HDL.
The current study findings strongly support the notion that dyslipidemias are more prevalent in patients with end-stage renal disease. It could be an independent causative factor for cardiovascular deaths in end-stage renal disease. Additional large-scale case-control studies are needed to further strengthen the above statement.
Key Words: End-Stage Renal Disease, Lipid Profile, Conventional Hemodialysis